In vitro Alternatives to Acute Inhalation Toxicity Studies in Animal Models—A Perspective

When assessing the risk and hazard of a non-pharmaceutical compound, the first step is determining acute toxicity, including toxicity following inhalation. Inhalation is a major exposure route for humans, and the respiratory epithelium is the first tissue that inhaled substances directly interact wi...

Full description

Bibliographic Details
Main Authors: Dania Movia, Solene Bruni-Favier, Adriele Prina-Mello
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fbioe.2020.00549/full
id doaj-dd0d554e6a5e434984dee15ce47c73db
record_format Article
spelling doaj-dd0d554e6a5e434984dee15ce47c73db2020-11-25T03:24:37ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852020-06-01810.3389/fbioe.2020.00549537898In vitro Alternatives to Acute Inhalation Toxicity Studies in Animal Models—A PerspectiveDania Movia0Solene Bruni-Favier1Adriele Prina-Mello2Adriele Prina-Mello3Laboratory for Biological Characterisation of Advanced Materials (LBCAM), Department of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College, The University of Dublin, Dublin, IrelandLaboratory for Biological Characterisation of Advanced Materials (LBCAM), Department of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College, The University of Dublin, Dublin, IrelandLaboratory for Biological Characterisation of Advanced Materials (LBCAM), Department of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College, The University of Dublin, Dublin, IrelandAMBER Centre, CRANN Institute, Trinity College, The University of Dublin, Dublin, IrelandWhen assessing the risk and hazard of a non-pharmaceutical compound, the first step is determining acute toxicity, including toxicity following inhalation. Inhalation is a major exposure route for humans, and the respiratory epithelium is the first tissue that inhaled substances directly interact with. Acute inhalation toxicity testing for regulatory purposes is currently performed only in rats and/or mice according to OECD TG403, TG436, and TG433 test guidelines. Such tests are biased by the differences in the respiratory tract architecture and function across species, making it difficult to draw conclusions on the potential hazard of inhaled compounds in humans. Research efforts have been therefore focused on developing alternative, human-relevant models, with emphasis on the creation of advanced In vitro models. To date, there is no In vitro model that has been accepted by regulatory agencies as a stand-alone replacement for inhalation toxicity testing in animals. Here, we provide a brief introduction to current OECD test guidelines for acute inhalation toxicity, the interspecies differences affecting the predictive value of such tests, and the current regulatory efforts to advance alternative approaches to animal-based inhalation toxicity studies. We then list the steps that should allow overcoming the current challenges in validating In vitro alternatives for the successful replacement of animal-based inhalation toxicity studies. These steps are inclusive and descriptive, and should be detailed when adopting in house-produced 3D cell models for inhalation tests. Hence, we provide a checklist of key parameters that should be reported in any future scientific publications for reproducibility and transparency.https://www.frontiersin.org/article/10.3389/fbioe.2020.00549/fulltoxicity testing alternativesinhalation studiesIn vitro alternativesair-liquid interface (ALI) culturelung epithelium
collection DOAJ
language English
format Article
sources DOAJ
author Dania Movia
Solene Bruni-Favier
Adriele Prina-Mello
Adriele Prina-Mello
spellingShingle Dania Movia
Solene Bruni-Favier
Adriele Prina-Mello
Adriele Prina-Mello
In vitro Alternatives to Acute Inhalation Toxicity Studies in Animal Models—A Perspective
Frontiers in Bioengineering and Biotechnology
toxicity testing alternatives
inhalation studies
In vitro alternatives
air-liquid interface (ALI) culture
lung epithelium
author_facet Dania Movia
Solene Bruni-Favier
Adriele Prina-Mello
Adriele Prina-Mello
author_sort Dania Movia
title In vitro Alternatives to Acute Inhalation Toxicity Studies in Animal Models—A Perspective
title_short In vitro Alternatives to Acute Inhalation Toxicity Studies in Animal Models—A Perspective
title_full In vitro Alternatives to Acute Inhalation Toxicity Studies in Animal Models—A Perspective
title_fullStr In vitro Alternatives to Acute Inhalation Toxicity Studies in Animal Models—A Perspective
title_full_unstemmed In vitro Alternatives to Acute Inhalation Toxicity Studies in Animal Models—A Perspective
title_sort in vitro alternatives to acute inhalation toxicity studies in animal models—a perspective
publisher Frontiers Media S.A.
series Frontiers in Bioengineering and Biotechnology
issn 2296-4185
publishDate 2020-06-01
description When assessing the risk and hazard of a non-pharmaceutical compound, the first step is determining acute toxicity, including toxicity following inhalation. Inhalation is a major exposure route for humans, and the respiratory epithelium is the first tissue that inhaled substances directly interact with. Acute inhalation toxicity testing for regulatory purposes is currently performed only in rats and/or mice according to OECD TG403, TG436, and TG433 test guidelines. Such tests are biased by the differences in the respiratory tract architecture and function across species, making it difficult to draw conclusions on the potential hazard of inhaled compounds in humans. Research efforts have been therefore focused on developing alternative, human-relevant models, with emphasis on the creation of advanced In vitro models. To date, there is no In vitro model that has been accepted by regulatory agencies as a stand-alone replacement for inhalation toxicity testing in animals. Here, we provide a brief introduction to current OECD test guidelines for acute inhalation toxicity, the interspecies differences affecting the predictive value of such tests, and the current regulatory efforts to advance alternative approaches to animal-based inhalation toxicity studies. We then list the steps that should allow overcoming the current challenges in validating In vitro alternatives for the successful replacement of animal-based inhalation toxicity studies. These steps are inclusive and descriptive, and should be detailed when adopting in house-produced 3D cell models for inhalation tests. Hence, we provide a checklist of key parameters that should be reported in any future scientific publications for reproducibility and transparency.
topic toxicity testing alternatives
inhalation studies
In vitro alternatives
air-liquid interface (ALI) culture
lung epithelium
url https://www.frontiersin.org/article/10.3389/fbioe.2020.00549/full
work_keys_str_mv AT daniamovia invitroalternativestoacuteinhalationtoxicitystudiesinanimalmodelsaperspective
AT solenebrunifavier invitroalternativestoacuteinhalationtoxicitystudiesinanimalmodelsaperspective
AT adrieleprinamello invitroalternativestoacuteinhalationtoxicitystudiesinanimalmodelsaperspective
AT adrieleprinamello invitroalternativestoacuteinhalationtoxicitystudiesinanimalmodelsaperspective
_version_ 1724601167515746304